The Journal of Urology
Volume 183, Issue 5 , Pages 1915-1920, May 2010

Progression of Lower Urinary Tract Symptoms in Older Men: A Community Based Study

  • J. Kellogg Parsons

      Affiliations

    • Division of Urologic Oncology, Moores Comprehensive Cancer Center and Division of Urology, San Diego Veterans Affairs Medical Center, University of California-San Diego, La Jolla, San Francisco, California
    • Corresponding Author InformationCorrespondence: c/o Leslie Parker, Division of Urology, University of Cailifornia-San Diego 200 West Arbor Dr., San Diego, California 92103-8897
  • ,
  • Timothy J. Wilt

      Affiliations

    • Section of General Medicine, Center for Chronic Disease Outcomes Research, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota
  • ,
  • Patty Y. Wang

      Affiliations

    • Department of Medicine (Bone and Mineral Unit), Oregon Health and Science University, Portland, Oregon
  • ,
  • Elizabeth Barrett-Connor

      Affiliations

    • Department of Family and Preventive Medicine, University of California-San Diego School of Medicine, La Jolla, San Francisco, California
  • ,
  • Douglas C. Bauer

      Affiliations

    • Department of Medicine, University of California-San Francisco, San Francisco, California
  • ,
  • Lynn M. Marshall

      Affiliations

    • Department of Orthopaedics and Rehabilitation, Oregon Health and Science University, Portland, Oregon
  • ,
  • Osteoporotic Fractures in Men Research Group

Received 24 September 2009 published online 18 March 2010.

Purpose

Lower urinary tract symptom progression in community dwelling older men is not well described.

Materials and Methods

We evaluated 5,697 participants in Osteoporotic Fractures in Men, a prospective cohort study of community dwelling men 65 years old or older. We characterized lower urinary tract symptoms using the American Urological Association symptom index at 2 time points, including at study entry and at 2-year followup. Progression was examined in the overall cohort and within baseline symptom strata (symptom index 7 or less and 8 or greater) using descriptive statistics.

Results

At baseline mean ± SD age was 73.5 ± 5.8 years and mean symptom index score was 8.3 ± 6.3 points. Mean and median total symptom index increased during followup by 1.1 ± 5.0 and 1.0 points, respectively. Of the 3,092 men with a symptom index of 7 points or less at baseline 883 (29%) reported lower urinary tract symptoms progression (8 points or greater) at followup. The incidence of lower urinary tract symptom progression increased with advancing baseline age. Of the 2,605 men with a symptom index of 8 points or greater at baseline 622 (24%) reported progression of at least 4 points at followup. Of the 2,200 men with a baseline symptom index of 7 points or less and no history of benign prostatic hyperplasia or lower urinary tract symptom treatment 94% remained untreated, 2% reported benign prostatic hyperplasia surgery and 4% reported medication use at followup.

Conclusions

Up to 29% of community dwelling older men with no or mild lower urinary tract symptoms will have clinically significant lower urinary tract symptoms within 2 years. These data help elucidate the natural history of lower urinary tract symptoms in the community and provide useful data to design clinical trials of lower urinary tract symptom prevention.

Key Words: prostate, urination disorders, prostatic hyperplasia, risk, epidemiology

Abbreviations and Acronyms: AUA-SI, American Urological Association symptom index, BPH, benign prostatic hyperplasia, LUTS, lower urinary tract symptoms, MrOS, Osteoporotic Fractures in Men

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Center for Research Resources, National Institute of Health Roadmap for Medical Research Grants U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810 and UL1 RR024140, Department of Defense Physician Research Training Award PC073412 (JKP), and National Cancer Institute Awards CA32102 and P30 CA23100-23 (JKP).

PII: S0022-5347(10)00027-3

doi:10.1016/j.juro.2010.01.026

The Journal of Urology
Volume 183, Issue 5 , Pages 1915-1920, May 2010